THE FAUCI FILES, Vol 3(19): HIV Cocktails Contraindicated in 40% of HIV-HepC Co-infected

fred fredshaw at primenet.com
Sat Jan 22 11:26:21 EST 2000


THE FAUCI FILES, Vol 3(19): HIV Cocktails Contraindicated in 40% of
HIV-HepC Co-infected 

January 21, 2000

NIH/NIAID Dictator-Direktor Dr. Anthony "Mussolini" Fauci
remains silent about the fact that the HIV HAART cocktail
drugs are so highly suppressive of localized CD8/CTL
immune responses in the liver that those who are
co-infected with Hepatitis C will experience a Hepatitis
C viral burst, which then leads to rapid tissue
destruction and loss of liver function.

Thus, the risk of early death is extremely high for
the HIV-HepC coinfected:

  "More than 40% of urban HIV-infected patients evaluated 
   recently were coinfected with hepatitis C virus"

Why does the Director in charge of infectious disease research
remain SILENT about this? 

Where are the advisories warning doctors NOT to prescribe these
potentially deadly drugs to the HIV-infected who are also
infected with Hepatitis C?

What the HELL is going on at the National Institutes of Health,
National Institute of Allergy and Infectious Disease, office
of the Director, Dr. Anthony "Mussolini" Fauci?

Perhaps the term "homoethnic cleansing" has more to do with
this than anything close to the concept of "medicine".

Crooked Murdering Bastards!

fred
----

Hepatitis C infection common in urban HIV-infected population

WESTPORT, Jan 18 (Reuters Health) - More than 40% of urban HIV-infected 
patients evaluated recently were coinfected with hepatitis C virus 
(HCV), according to a report by New York City-based investigators. 
 
Dr David M. Weinstock, of the New York Presbyterian Hospital/Cornell 
University Medical Center, and associates determined the HCV 
seropositivity rate for 1623 HIV-infected patients seen at the Center 
for Special Studies at the New York Presbyterian Hospital. 
 
They found that 41.3% of the patients were also seropositive for HCV. In
addition, 88.8% of the HCV-seropositive subjects tested positive for 
hepatitis B virus (HBV). 
 
"Hemophiliacs, intravenous drug users, and patients positive for HBV 
were significantly more likely to be HCV positive," the investigators 
report in the December 24th issue of AIDS. "HCV seroprevalence did not 
differ significantly with respect to sex or race." 
 
The results of multivariate analysis revealed an independent association
between HCV infection and older age and HBV seropositivity. HIV risk 
factors that were independently associated with HCV seropositivity 
included "...hemophilia, intravenous drug use, and unprotected 
heterosexual contact." 
 
While unprotected heterosexual contact was an independent risk factor 
for HCV, homosexual contact was not. Dr Weinstock's group suggests that 
this difference may be "...caused by the under-reporting of risk factors
by patients included in the unprotected heterosexual group." 
 
Overall, they conclude that the urban HIV-infected population studied 
has high rates of HCV and HBV coinfection. 
 
Earlier detection of HIV, combined with the availability of highly 
active antiretroviral therapy for HIV infection, has resulted in fewer 
opportunistic infections and more comorbid illnesses such as hepatitis, 
the researchers point out. Therefore, "...new and more efficacious 
prevention and treatment..." of hepatitis is needed. 
 
AIDS 1999;13:2593-2595. 






More information about the Immuno mailing list